Modafinil
| Modafinil | |
|---|---|
| Salts [] | |
|---|---|
| Modafinil hydrochloride | |
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 273.40 g/mol [1] |
| Appearance | White to off-white crystalline powder [1] |
| Melting point | 164-166 °C [1] |
| Solubility | Slightly soluble [1] |
| Predicted LogP | 1.7 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C15H15NO2S |
| IUPAC name | 2-benzhydrylsulfinylacetamide |
| SMILES | C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N |
| InChI | InChI=1S/C15H15NO2S/c16-14(17)11-19(18)15(12-7-3-1-4-8-12)13-9-5-2-6-10-13/h1-10,15H,11H2,(H2,16,17) |
| InChIKey | YFGHCGITMMYXAQ-UHFFFAOYSA-N |
| CAS number | 68693-11-8 |
| UNII | R3UK8X3U3D |
| PubChem CID | 4236 |
| Pharmacokinetics[] | |
|---|---|
| Onset | 2–4 hour (peak) |
| Elimination half-life | Modafinil: 12–15 hour, Armodafinil: 10–17 hour, Esmodafinil: 3–5 hour[3] |
| Duration of action | 11.5 hour |
| Metabolism | Liver (amide hydrolysis, S-oxidation, aromatic ring hydroxylation, glucuronide conjugation; CYP1A2, CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5 involved) |
| Excretion | Urine: 80% (≤10% as modafinil, 35–51 % as modafinil acid), Feces: 1.0% |
| Routes of administration | Oral (tablets) |
| Dependence liability | Relatively low |
| Addiction liability | Low |
Modafinil (also known as Provigil, Modiodal, 2-(Benzhydrylsulfinyl)acetamide, 2-[(diphenylmethyl)sulfinyl]acetamide, modaphonil, Modafinilo, Crl 40476, Modafinilum, Modafinil civ or R Modafinil) is a eugeroic substance.
Chemistry
Salts []
Stereochemistry []
Modafinil is a racemic mixture of the enantiomers (optical activity ( + / - )).
Druglikeness
Lipinski's rule of five
Modafinil matches Lipinski's rule of five.Reagents
There are currently 5 reagent-interactions on DrugsPRO
| Reagent | Color change | Description |
|---|---|---|
| Marquis | yellow/orange > brown | |
| Mecke | orange > brown | |
| Mandelin | brownish red | |
| Liebermann | darkening orange | |
| Froehde | deep orange / red |
Pharmacology
ATC Classification
- nervous system (N)
- psychoanaleptics (N06)
- psychostimulants, agents used for adhd and nootropics (N06B)
- centrally acting sympathomimetics (N06BA)
- (N06BA07)
- modafinil (N06BA07)
MeSH Classification
- central nervous system stimulants (M0001063)
- wakefulness-promoting agents (M0582998)
- cytochrome p-450 cyp3a inducers (M0590399)
Mechanism of action []
The exact mechanism of action is unclear, although <i>in vitro</i> studies have shown it to inhibit the reuptake of dopamine by binding to the dopamine reuptake pump, and lead to an increase in extracellular dopamine. Modafinil activates glutamatergic circuits while inhibiting GABA. Modafinil is thought to have less potential for abuse than other stimulants due to the absence of any significant euphoric or pleasurable effects. It is possible that modafinil acts by a synergistic combination of mechanisms including direct inhibition of dopamine reuptake, indirect inhibition of noradrenalin reuptake in the VLPO and orexin activation. Modafinil has partial alpha 1B-adrenergic agonist effects by directly stimulating the receptors. [1]
Interactions []
Medical side effects []
197 side effects listed on drug labels in SIDER 4.1 (modafinil).
- Nausea
- Dizziness
- Syncope
- Insomnia
- Anxiety
- Diarrhoea
- Loose stools
- Dry mouth
- Depression
- Depression aggravated
- Anxiety depression
- Dyspepsia
- Dermatitis
- Rash
- Asthenia
- Fatigue
- Headache
- Palpitations
- Abdominal pain upper
- Decreased appetite
- Conjunctivitis
- Constipation
- Dermatitis contact
- Dyspnoea
- Body temperature increased
- Seasonal allergy
- Rhinitis seasonal
- Hyperhidrosis
- Sweating
- Nervousness
- Tension
- Pain
- Paraesthesia
- Polyuria
- Urine output increased
- Pruritus
- Tachycardia
- Thirst
- Tremor
- Vomiting
- Agitation
- Hyperkinesia
- Migraine
- Gamma-glutamyltransferase increased
- Disturbance in attention
- Depressed mood
- Influenza like illness
- Pollakiuria
- Muscle twitching
- Ataxia
- Cystitis
- Bladder pain
- Cystitis noninfective
- Hearing impaired
- Cardiac arrest
- Leukocytosis
- Personality disorder
- Hyperacusis
- Pain in jaw
- Erectile dysfunction
- Photosensitivity reaction
- Muscular weakness
- Abdominal pain
- Gastrointestinal pain
- Aggression
- Agranulocytosis
- Anaphylactic shock
- Anaphylactoid reaction
- Angioedema
- Arrhythmia
- Mental disorder
- Chest pain
- Confusional state
- Feeling abnormal
- Malaise
- Connective tissue disorder
- Delusion
- Drug eruption
- Dyskinesia
- Orofacial dyskinesia
- Eczema
- Oedema
- Eosinophilia
- Toxic epidermal necrolysis
- Erythema multiforme
- Stevens-Johnson syndrome
- Gastrointestinal disorder
- Hallucination
- Cardiac disorder
- Hypersensitivity
- Hypertension
- Immune system disorder
- Irritability
- Nervous system disorder
- Psychotic disorder
- Convulsion
- Suicide attempt
- Urethral disorder
- Urinary tract disorder
- Urticaria
- Angiopathy
- Weight increased
- Weight decreased
- Myocardial ischaemia
- Skin disorder
- Discomfort
- Ill-defined disorder
- Thinking abnormal
- Mental disability
- Condition aggravated
- Mania
- Suicidal ideation
- Blood pressure increased
- Electrocardiogram abnormal
- Urine odour abnormal
- Tardive dyskinesia
- Albuminuria
- Amblyopia
- Amnesia
- Anaemia
- Arthralgia
- Musculoskeletal discomfort
- Myalgia
- Arthritis
- Asthma
- Back pain
- Bronchitis
- Cataplexy
- Neck pain
- Infection
- Cough
- Cough increased
- Libido decreased
- Disturbance in sexual arousal
- Somnolence
- Dysgeusia
- Dysmenorrhoea
- Ear disorder
- Ear pain
- Ecchymosis
- Epistaxis
- Flatulence
- Gastroenteritis
- Gingivitis
- Haematuria
- Herpes simplex
- Hyperglycaemia
- Hypotension
- Body temperature decreased
- Hypothermia
- Influenza
- Arthropathy
- Osteoarthritis
- Muscle spasms
- Lung disorder
- Mediastinal disorder
- Hypertonia
- Obesity
- Pancytopenia
- Tooth abscess
- Pharyngitis
- Pneumonia
- Psoriasis
- Pyuria
- Rhinitis
- Sinusitis
- Shock
- Loss of consciousness
- Tooth disorder
- Urinary tract infection
- Vasodilation procedure
- Vertigo
- Viral infection
- Urinary retention
- Chills
- Mood swings
- Affect lability
- Oedema peripheral
- Hepatic function abnormal
- Stomatitis
- Mouth ulceration
- Musculoskeletal stiffness
- Nuchal rigidity
- Ventricular extrasystoles
- Injury
- Eye pain
- Aspartate aminotransferase increased
- Dry skin
- Malnutrition
- Increased appetite
- Psychiatric symptom
- Urine abnormality
- Urine analysis abnormal
- Hepatic enzyme increased
- Bradycardia
- Ejaculation disorder
- Visual impairment
Indications
- Apnoea
- Cataplexy
- Dyskinesia
- Excessive daytime sleepiness
- Fatigue
- Hypersomnia
- Hypopnea syndrome
- Narcolepsy
- Obstructive sleep apnea syndrome
- Sleep disorder
- Wakefulness
Subjective effects []
| 0xea / Modafinil [] | |
|---|---|
Routes:
| |
| alina / Modafinil [] | |
|---|---|
Routes:
| |
| bonzi / Modafinil [] | |
|---|---|
Routes:
| |
| nervewing / Modafinil [] | |
|---|---|
| ninerik / Modafinil [] | |
|---|---|
Routes:
| |
Experience reports
Erowid
There are currently 30 experience reports involving modafinil on Erowid: []- "Two Years and Zero Regrets" by EF 1610
- "Competitive Edge" by Worker Bee
- "Great Feeling to Terrible Night" by Tyyrant
- "One Year On" by User agent
- "A New Feeling" by J.S
- "Subtle Consciousness Altering" by SimSim314
- "Alert, Happy and Retentive" by Anonymous
- "First Impression" by Oxonian
- "3 Months of Active Psychosis Horror" by Joe
- "Completely Addictive" by supposedlysober
- "Epiphany, It Seemed" by Dr S.
- "Cut Through the Head Fog" by Carnage
- "My Experiment with Smart Drugs" by Johann Hari
- "A Student's Take" by Greedo
- "Chasing Mental Clarity" by PoppyShef
- "Red Blood Cells in Party Hats" by The Elf
- "Returning to a Level of Balance" by Shasta
- "An Autistic Perspective" by Careful_Dave
- "I Feel Like Me for the First Time in Years" by Anonymous
- "That Extra Mental Edge" by SupernovaNights
- "Finally a Weapon to Slay the Fatigue Dragon" by Jack Trust
- "For Excessive Sleepiness" by deedee
- "The Experiments Retrospective" by Initialised
- "It's Just a Dream" by Alberto
- "Heart Problems?" by Lerdob
- "Better Waking Through Chemistry" by Larry Smith
- "Caffeine's Smarter Sibling" by Medifinil
- "It Helps Me Study, but It's No Magic Pill" by galvani
- "First and Continued Use" by Action Jackson
- "Concentration Depression Awake" by dustybin
- "15 years of drug use ended by a single mushroom" by oxide-NL (74 upvotes)
- "First times psychedelics: psilocybe cubensis 0.5g, 1g, 1.5g, alone" by LocksmithRelevant594 (11 upvotes)
- "A Galaxy Far Far Away [No Spoilers](100mg+ 3-meo-pcp,3g mushrooms, weed) (x/post Drugs)" by BringBackMXE (5 upvotes)
- "There are 45 psychedelic and dissociative trip reports in the Drug Users Bible: Download a free copy from here. Whether psychedelics are used for recreation, you need to look after yourself. Stay safe." by DMTrott (3 upvotes)
- "DXM Trip Report - Self experimentation for Depression" by Spiritual_West1540 (3 upvotes)
- "Ket and promethazine" by toasted170 (3 upvotes)
Legal status []
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 4236, Modafinil. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/4236
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Modafinil. UNII: R3UK8X3U3D. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/R3UK8X3U3D
Niemegeers P, Maudens KE, Morrens M, Patteet L, Joos L, Neels H, Sabbe BG. Pharmacokinetic evaluation of armodafinil for the treatment of bipolar depression. Expert Opin Drug Metab Toxicol. September 2012; 8(9):1189–1197. PMID 22803602. https://doi.org/10.1517/17425255.2012.708338
RDC Nº 784 – Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. March 31, 2023. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992
Modafinil Product information. Health Canada. April 25, 2012. https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63139
Modafinil Orion, Tablett 100 mg. FASS. 6 October 2023. https://fass.se/health/product/20141031000035/fass-text
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 10:21:53 |
| drugspro | ok | 2026-11-20 10:21:49 |
| erowid | ok | 2026-11-20 10:21:51 |
| gsrs | ok | 2026-11-20 10:21:50 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0014883) | 2026-11-20 10:21:49 |
| kegg | ok | 2026-11-20 10:21:51 |
| pubchem | ok | 2026-11-20 10:21:47 |
| ok | 2026-11-20 10:21:49 | |
| sider | ok | 2026-11-20 10:21:49 |
| structure | ok | 2026-11-20 10:21:49 |
| wikipedia | ok | 2026-11-20 10:21:49 |